(Q28370897)

English

Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination (English)

0 references

1 reference

1 reference

M Fukano

1

0 references

S Amano

series ordinal

2

0 references

J Sato

series ordinal

3

0 references

K Yamamoto

series ordinal

4

0 references

H Adachi

series ordinal

5

0 references

H Okabe

series ordinal

6

0 references

Y Fujiyama

series ordinal

7

0 references

T Bamba

series ordinal

8

0 references

language of work or name

English

0 references

publication date

February 2000

0 references

published in

Human Pathology

0 references

volume

31

0 references

issue

2

0 references

page(s)

250-3

0 references

cites work

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic dysfunction associated with troglitazone

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel antidiabetic drug, troglitazone--reason for hope and concern

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone (CS-045): a new antidiabetic agent

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

An autopsy case of troglitazone-induced fulminant hepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0046-8177%2800%2980229-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0046-8177(00)80229-4

0 references

PubMed ID

10685643

0 references

(Q28370897)

Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)